Clinical Trials Browser

Completed × Carcinoma, Non-Small-Cell Lung × Blood Specimen Collection × Clear all

Carcinoma, Non-Small-Cell Lung

NCT04951154 2025-08-19

A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

Completed

33 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04180176 2024-01-17

PCG

Phase 4 Completed

945 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT04487457 2023-04-06

CINECI

Completed

31 enrolled

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03258788 2023-04-03

PD-RAD

Completed

15 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04154163 2022-02-28

ADOPT

Completed

18 enrolled

DermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma, Ovarian Neoplasms

NCT01209520 2015-02-24

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Phase NA Completed

6 enrolled 6 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinogenesis

NCT01936571 2014-04-11

Usefulness of Blood Biomarkers for Overall Survival in NSCLC

Completed

250 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

MetLung

A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

PCG

CINECI

PD-RAD

ADOPT

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Usefulness of Blood Biomarkers for Overall Survival in NSCLC